Standard Biotools Inc.
LAB· Nasdaq
Standard Biotools Inc.
- Last sale
- Oct 1, 2026 · -0.56%
- Market cap
- $287.45M
- 392.58M shares
- Filings
- 1,042
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $85,331,000 | reported | |
| FY 2024 | 2024-12-31 | $91,008,000 revised | reported | |
| FY 2023 | 2023-12-31 | $106,340,000 | reported | |
| FY 2022 | 2022-12-31 | $97,948,000 | reported | |
| FY 2021 | 2021-12-31 | $130,581,000 | reported | |
| FY 2020 | 2020-12-31 | $138,144,000 | reported | |
| FY 2019 | 2019-12-31 | $117,243,000 | reported | |
| FY 2018 | 2018-12-31 | $112,964,000 | reported | |
| FY 2017 | 2017-12-31 | $101,937,000 | reported | |
| FY 2016 | 2016-12-31 | $104,446,000 | reported | |
| FY 2015 | 2015-12-31 | $114,712,000 | reported | |
| FY 2014 | 2014-12-31 | $116,456,000 | reported |
Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR
